Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
downsides. Removing needless barriers to lifesaving and life-enhancing therapies is exactly the sort of reform AFP exists